1. The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings

   • Panos Kanavos

   Current Opinion 27 October 2012 Pages: 523 - 532

2. Stratified Administration of Serotonin 5-HT₃ Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis

   • Lisa A. Sanchez
   • Mark Holdsworth
   • Sylvia B. Bartel

   Review Article 27 October 2012 Pages: 533 - 556

   

3. Effectiveness of Eletriptan in Reducing Time Loss Caused by Migraine Attacks

   • Nicholas E. J. Wells
   • Timothy J. Steiner

   Original Research Article 27 October 2012 Pages: 557 - 566

   

4. Olanzapine versus Risperidone

   • Eric T. Edgell
   • Scott W. Andersen
   • Alan Breier

   Original Research Article 27 October 2012 Pages: 567 - 579

   

5. Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention

   • Maureen J. Lage
   • Beth L. Barber
   • Daniel E. Ball

   Original Research Article 27 October 2012 Pages: 581 - 589

   

6. Inhaled Salmeterol/Fluticasone Propionate Combination

   • Anthony Markham
   • Julie C. Adkins
   • Blair Jarvis

   Adis Pharmacoeconomic Drug Evaluation 27 October 2012 Pages: 591 - 608

   

7. Potential Savings in the Cost of Caring for Alzheimer’s Disease

   • Karen W. Linkins
   • John R. Lloyd
   • Holly J. Strausbaugh

   Correspondence 27 October 2012 Pages: 609 - 609

8. Potential Savings in the Cost of Caring for Alzheimer’s Disease

   • A. Brett Hauber
   • Josephine A. Mauskopf
   • Edward H. Snyder

   Correspondence 27 October 2012 Pages: 609 - 612